Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Histopathology Stories

2011-09-29 06:36:00

OKLAHOMA CITY, Sept. 29 2011 /PRNewswire/ -- Security First International Holdings Inc., (Pink Sheets:SCFR.pk - News) We are pleased to announce our Quantum Magnetic Resonance Analyzer initial testing of multiple subjects both male and female of varying age groups resulted in results that were extremely pleasing to SCFR as well as the people tested, the quickness of receiving the test results allowed testing of many individuals in a short time period. With the Quantum Magnetic Resonance...

2011-09-22 12:11:37

In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization. The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days of biopsy compared to a 2.9 percent hospitalization rate among a control group of men who did not have a prostate biopsy. The study,...

2011-08-29 12:04:04

Preventing the formation of amyloid fibrils A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds. The discovery could lead to new methods to identify drugs to prevent, treat or halt the progression of other conditions in which amyloid fibrils play a part, including Alzheimer's, Parkinson's and Type II diabetes. The research, funded by...

2011-08-11 21:25:55

Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Progression of disease, which can precede cancer, was rare in patients who underwent RFA treatment, and there was no procedure- or cancer-related mortality. "This study reports the longest duration of follow-up of patients undergoing...

2011-07-07 06:52:34

(Ivanhoe Newswire) "“ The little-studied amyloid peptide may be promoting Alzheimer's disease (AD), according to this study. Their findings show that the peptide is more abundant, more neurotoxic, and exhibits a higher propensity to aggregate than other agents studied earlier. An irreversible, progressive brain disease affecting millions worldwide, Alzheimer's disease is devastating for its victims, robbing them of their memory and cognitive skills and ultimately of their lives. Even...

2011-07-04 12:39:41

Highly aggregative and neurotoxic amyloid peptide A-beta-43 points the way to new approaches for AD diagnosis and treatment Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease (AD). Their surprising findings reveal that the peptide is more abundant, more neurotoxic, and exhibits a higher propensity to aggregate than amyloidogenic agents studied in earlier research,...

2011-07-03 12:35:02

Highly aggregative and neurotoxic amyloid peptide Abeta43 points the way to new approaches for AD diagnosis and treatmentTokyo, July 4, 2011 - (ACN Newswire) - Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease (AD). Their surprising findings reveal that the peptide is more abundant, more neurotoxic, and exhibits a higher propensity to aggregate than amyloidogenic...

2011-06-29 18:13:55

Overexpression of gene is linked with Alzheimer's disease and down syndrome Chronic stress has long been linked with neurodegeneration. Scientists at USC now think they may know why. The study, which has tremendous implications for understanding and treating Alzheimer's disease, was published in the June issue of The FASEB Journal (the Journal of the Federation of American Societies for Experimental Biology). Corresponding author Kelvin J. A. Davies, the James E. Birren Chair at the USC Davis...

2011-06-22 14:05:49

University of Tennessee molecular biophysics professor reveals a key trigger to a rare but deadly neurodegenerative disease Jeremy Smith, Governor's Chair for Molecular Biophysics at the University of Tennessee, Knoxville, has helped reveal a key trigger of Gerstmann"“Sträussler"“Scheinker (GSS) syndrome, a rare but deadly neurodegenerative disease. The finding could have far-reaching implications for the treatment of other neurodegenerative diseases such as Alzheimer's,...

2011-06-15 07:48:00

-20-month extension of the Gen-Probe license- QUEBEC CITY, June 15, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio. Moreover, in addition to providing greater patent protection, this new patent bears an extended expiration...